Dietary modulation of intestinal microbiota as trigger of liver health: role of bile acids

HDHL INTIMIC cofunded call “Interrelation of the Intestinal Microbiome, Diet and Health” (IM 2017)
Dietary modulation of intestinal microbiota as trigger of liver health: role of bile acids
Di-Mi-Liv
2018-04-01
2021-12-31
Prof. Dr. Ina Bergheim
University of Vienna
Austria

Consortium

Partner Organization Partner Country
University Clinic RWTH AachenGermany
Medical University of ViennaAustria
University of GothenburgSweden
University of HohenheimGermany

1. Overall project description


1.1 Summary

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Genetic predisposition and general overnutrition are discussed as key factors in the development of NAFLD; however, alterations of intestinal microbiota composition and associated impairments of intestinal barrier function are thought to be critical in the onset and progression of NAFLD. In recent years, studies also suggest a pivotal role of bile acids and microbial bile acid metabolism as mediators of gut-liver-crosstalk subsequently affecting NAFLD initiation and progression. Soluble fibers like oat β-glucans bind bile acids and have been proposed to modulate intestinal microbiota composition thereby affecting metabolic parameters and liver health. Based on this background the main aim of the present transnational project is to reveal a causal relationship between specific diet-responsive microbial taxa and alterations of the bile acid pool as risk factor for initiation and progression of metabolic liver diseases. Herein, the effects of the soluble fibre oat β-glucan will be assessed. With this project the 5 partners aim to contribute to the understanding of the mechanisms involved in the development of NAFLD and to build the basis for new nutrition based therapeutic approaches.


1.2 Highlights

Not applicable so far, as work is still in progress.


4. Impact


4.1 List of publications

AuthorsTitleYear, Issue, PPPartners NumberDoiPdf
Ina Bergheim, Hanns-Ulrich Marschall, Kai Markus Schneider, Christian TrautweinIntestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis2019http://dx.doi.org/10.1136/gutjnl-2018-316670
Kai Markus Schneider, Christian TrautweinIntestinal microbiota protects against MCD diet induced steatohepatitis201910.3390/ijms20020308

4.2 Presentation of the project

Target groupAuthorsMeans of communicationHyperlinkPdf
International Hepatology Community Ina Bergheim, Hanns-Ulrich Marschall, Kai Markus Schneider, Christian Trautwein, Talk: : “Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis”, EASL ILC, Vienna 2019Oral Presentation

4.3 List of submitted patents and other outputs

Patent licencePartners involvedYearInternational eu or national patentCommentPdf

BACK
WU Logo
This project has received funding from the European Union’s
H2020 Research and Innovation Programme under grant agreement n.696300

We use cookies to improve our website and your experience when using it. By continuing to navigate this site, you agree to the cookie policy. To find out more about the cookies we use and how to delete them, see our privacy policy.

  I accept cookies from this site.
EU Cookie Directive Module Information